We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Check if you can claim relief from VAT if you supply goods or services to a customer, but you are not paid.
How to prepare and what to do if you’re affected by extreme weather and natural hazards while travelling or living abroad.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
How to use a cost benefit analysis to evaluate your digital health product.
Information on methyl ethyl ketone (MEK) (also known as 2-butanone) for use in responding to chemical incidents.
Guidance for policy officials in government to identify and assess the wider environmental impacts of their policy options.
National reports and tool to support the monitoring of the direct and indirect impacts of COVID-19 on the population.
How to use a cost consequence analysis to evaluate your digital health product.
Information on chloroform (also known as trichloromethane or methyl trichloride), for use in responding to chemical incidents.
You may need to tell DVLA if you have cancer - if you do, download the correct form to let them know
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
How to use a before-and-after study to evaluate your digital health product.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
Helping public health practitioners conducting evaluations – using process evaluations to explain how complex interventions work.
You may need to tell DVLA If you have Hodgkin's lymphoma
Why it's important to evaluate digital health products that have been developed rapidly and how to choose evaluation methods in these circumstances.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).